Literature DB >> 9727848

Thiamine-responsive lactic acidaemia: role of pyruvate dehydrogenase complex.

E Naito1, M Ito, I Yokota, T Saijo, J Matsuda, Y Kuroda.   

Abstract

UNLABELLED: Lactic acidaemia is sometimes associated with a defect of the pyruvate dehydrogenase complex (PDHC), catalysing the thiamine-dependent decarboxylation of pyruvate. The activity of PDHC for different thiamine pyrophosphate (TPP) concentrations was determined in 13 patients with lactic acidaemia, clinically responsive to thiamine treatment in order to assess the role of PDHC in the aetiology of thiamine-responsive lactic acidaemia. Culture of lymphoblastoid cells and skin fibroblasts and muscle biopsies were performed in these 13 patients. The activity of PDHC to sodium dichloroacetate (DCA), known as the activator of PDHC, was also examined. Three groups were identified according to PDHC activity. Group 1 (two patients) displayed very low PDHC activity, which was not increased by DCA. This PDHC activity increased at high TPP concentrations. Group 2 (five patients) displayed below normal PDHC activity at low TPP concentrations, increased by DCA. This PDHC activity became normal at high TPP concentrations. PDHC deficiency in these patients of groups 1 and 2 was due to a decreased affinity of PDHC for TPP. Group 3 included six patients with normal PDHC activity at low as well as high TPP concentrations. This PDHC activity was increased by DCA.
CONCLUSION: High concentrations of TPP may be required for maximal activity of PDHC in some patients with lactic acidaemia. The assay of PDHC activity, performed at a low concentration of TPP (1 x 10(-4)mM) allows selection of patients with thiamine-responsive lactic acidaemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727848     DOI: 10.1007/s004310050903

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

2.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

3.  Pyruvate Dehydrogenase Activity and Quantity Decreases After Coronary Artery Bypass Grafting: a Prospective Observational Study.

Authors:  Lars W Andersen; Xiaowen Liu; Teng J Peng; Tyler A Giberson; Kamal R Khabbaz; Michael W Donnino
Journal:  Shock       Date:  2015-03       Impact factor: 3.454

4.  Mitochondrial protection attenuates inflammation-induced impairment of neurogenesis in vitro and in vivo.

Authors:  Ludmila A Voloboueva; Star W Lee; John F Emery; Theo D Palmer; Rona G Giffard
Journal:  J Neurosci       Date:  2010-09-15       Impact factor: 6.167

5.  Mitochondrial Disease.

Authors:  Roser Pons; Darryl C. De Vivo
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

6.  Acute renal failure and type B lactic acidosis as first manifestation of extranodal T-cell lymphoblastic lymphoma.

Authors:  Seongseok Yun; Courtney N Walker; Nicole D Vincelette; Faiz Anwer
Journal:  BMJ Case Rep       Date:  2014-06-09

Review 7.  Thiamine (vitamin B1) in septic shock: a targeted therapy.

Authors:  Ari Moskowitz; Michael W Donnino
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

8.  The role of vitamins and minerals in psychiatry.

Authors:  Stacey Cornish; Lewis Mehl-Madrona
Journal:  Integr Med Insights       Date:  2008-09-24

9.  Thiamine as an adjunctive therapy in cardiac surgery: a randomized, double-blind, placebo-controlled, phase II trial.

Authors:  Lars W Andersen; Mathias J Holmberg; Katherine M Berg; Maureen Chase; Michael N Cocchi; Christopher Sulmonte; Julia Balkema; Mary MacDonald; Sophia Montissol; Venkatachalam Senthilnathan; David Liu; Kamal Khabbaz; Adam Lerner; Victor Novack; Xiaowen Liu; Michael W Donnino
Journal:  Crit Care       Date:  2016-03-14       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.